Various
biopolymers, including gelatin, have already been applied
to serve a plethora of tissue engineering purposes. However, substantial
concerns have arisen related to the safety and the reproducibility
of these materials due to their animal origin and the risk associated
with pathogen transmission as well as batch-to-batch variations. Therefore,
researchers have been focusing their attention toward recombinant
materials that can be produced in a laboratory with full reproducibility
and can be designed according to specific needs (e.g., by introducing
additional RGD sequences). In the present study, a recombinant protein
based on collagen type I (RCPhC1) was functionalized with photo-cross-linkable
methacrylamide (RCPhC1-MA), norbornene (RCPhC1-NB), or thiol (RCPhC1-SH)
functionalities to enable high-resolution 3D printing via two-photon
polymerization (2PP). The results indicated a clear difference in
2PP processing capabilities between the chain-growth-polymerized RCPhC1-MA
and the step-growth-polymerized RCPhC1-NB/SH. More specifically, reduced
swelling-related deformations resulting in a superior CAD-CAM mimicry
were obtained for the RCPhC1-NB/SH hydrogels. In addition, RCPhC1-NB/SH
allowed the processing of the material in the presence of adipose
tissue–derived stem cells that survived the encapsulation process
and also were able to proliferate when embedded in the printed structures.
As a consequence, it is the first time that successful HD bioprinting
with cell encapsulation is reported for recombinant hydrogel bioinks.
Therefore, these results can be a stepping stone toward various tissue
engineering applications.